Digital twins to personalize medicine
- PMID: 31892363
- PMCID: PMC6938608
- DOI: 10.1186/s13073-019-0701-3
Digital twins to personalize medicine
Abstract
Personalized medicine requires the integration and processing of vast amounts of data. Here, we propose a solution to this challenge that is based on constructing Digital Twins. These are high-resolution models of individual patients that are computationally treated with thousands of drugs to find the drug that is optimal for the patient.
Conflict of interest statement
The authors are members of the SDTC, and MB is associated with DigiTwin (
Figures
References
-
- US Food and Drug Administration . Paving the way for personalized medicine: FDA’s role in a new era of medical product development. Silver Spring: US Food and Drug Administration; 2013.
